Molecular events in the cardiomyopathy of sepsis

Molecular Medicine

Volumn 14, Issue 5-6, 2008, Pages 327-336

  Flierl, Michael A ^a   Rittirsch, Daniel ^a   Huber Lang, Markus S ^b   Sarma, J Vidya ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CD14 ANTIGEN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PEROXYNITRITE; TOLL LIKE RECEPTOR;

APOPTOSIS; ARTICLE; AUTONOMIC DYSFUNCTION; CALCIUM TRANSPORT; CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; CYTOLOGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; METABOLISM; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMYOPATHIES; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; PEROXYNITROUS ACID; SEPSIS; SHOCK, SEPTIC;

EID: 44649115085     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00130.Flierl     Document Type: Article

References (152)

1. MacLean LD, Mulligan WG, McLean AP, Duff JH. (1967) Patterns of septic shock in man: a detailed study of 56 patients. Ann. Surg. 166:543-62.
2. Waisbren BA. (1951) Bacteremia due to gram-negative bacilli other than the Salmonella; a clinical and therapeutic study. AMA. Arch. Intern. Med. 88:467-88.
3. Rabuel C, Mebazaa A. (2006) Septic shock: a heart story since the 1960s. Intensive. Care. Med. 32:799-807.
4. Clowes GH Jr, Vucinic M, Weidner MG. (1966) Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases. Ann. Surg. 163:866-85.
5. Maclean LD, Spink WW, Visscher MB, Weil MH. (1956) Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J. Clin. Invest. 35:1191-8.
6. Postel J, Schloerb PR. (1977) Cardiac depression in bacteremia. Ann. Surg. 186:74-82.
7. Wilson RF, Sarver EJ, LeBlanc PL. (1971) Factors affecting hemodynamics in clinical shock with sepsis. Ann. Surg. 174:939-43.
8. Packman MI, Rackow EC. (1983) Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit. Care Med. 11:165-9.
9. Gunnar RM, Loeb HS, Winslow EJ, Blain C, Robinson J. (1973) Hemodynamic measurements in bacteremia and septic shock in man. J. Infect. Dis. 128 (Suppl):295-8.
10. Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM. (1973) Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am. J. Med. 54:421-32.
11. Krausz MM, Perel A, Eimerl D, Cotev S. (1977) Cardiopulmonary effects of volume loading in patients in septic shock. Ann. Surg. 185:429-34.
12. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE. (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit. Care Med. 15:923-9.
13. Parker MM, et al. (1984) Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100:483-90.
14. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE. (1990) Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97:126-31.
15. Ellrodt AG, et al. (1985) Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am. Heart. J. 110:402-9.
16. Natanson C, et al. (1989) Role of endotoxemia in cardiovascular dysfunction and mortality: Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J. Clin. Invest. 83:243-51.
17. Natanson C, et al. (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:823-32.
18. Jones AE, Craddock PA, Tayal VS, Kline JA. (2005) Diagnostic accuracy of left ventricular function for identifying sepsis among emergency department patients with nontraumatic symptomatic undifferentiated hypotension. Shock 24:513-7.
19. Jardin F, et al. (1999) Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 116:1354-9.
20. Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA. (1997) Left ventricular systolic and diastolic function in septic shock. Intensive Care Med. 23:553-60.
21. Charpentier J, et al. (2004) Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med. 32:660-5.
22. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. (1986) The coronary circulation in human septic shock. Circulation 73:637-44.
23. Dhainaut JF, et al. (1987) Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75:533-41.
24. Wu AH. (2001) Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 27:959-61.
25. Lanone S, et al. (2000) Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway. Am. J. Respir. Crit. Care Med. 162:2308-15.
26. Groeneveld AB, et al. (1991) Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc. Res. 25:80-8.
27. Solomon MA, et al. (1994) Myocardial energy metabolism and morphology in a canine model of sepsis. Am. J. Physiol. 266:H757-68.
28. Madorin WS, et al. (2004) Cardiac myocytes activated by septic plasma promote neutrophil transendothelial migration: role of platelet-activating factor and the chemokines LIX and KC. Circ. Res. 94:944-51.
29. Chagnon F, Bentourkia M, Lecomte R, Lessard M, Lesur O. (2006) Endotoxin-induced heart dysfunction in rats: assessment of myocardial perfusion and permeability and the role of fluid resuscitation. Crit. Care Med. 34:127-33.
30. Yu P, et al. (1997) Myocardial collagen changes and edema in rats with hyperdynamic sepsis. Crit. Care Med. 25:657-62.
31. 18F]fluoromisonidazole. Am. J. Physiol. 261:R965-72.
32. Wangensteen SL, Geissinger WT, Lovett WL, Glenn TM, Lefer AM. (1971) Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. Surgery 69:410-8.
33. Parrillo JE, et al. (1985) A circulating myocardial depressant substance in humans with septic shock: septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76:1539-53.
34. Kumar A, et al. (1996) Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 183:949-58.
35. Finkel MS, et al. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-9.
36. Niederbichler AD, et al. (2006) An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J. Exp. Med. 203:53-61.
37. Carlson DL, Willis MS, White DJ, Horton JW, Giroir BP. (2005) Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit. Care Med. 33:1021-8.
38. Garner LB, et al. (2003) Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am. J. Physiol. Heart. Circ. Physiol. 285:H2500-9.
39. Maass DL, White J, Horton JW. (2002) IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 18:360-6.
40. Gao H, Neff T, Ward P.A. (2006) Regulation of lung inflammation in the model of IgG immune-complex injury. Annu. Rev. Pathol. Mech. Dis. 1:215-42.
41. Huber-Lang MS, et al. (2002) Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169:3223-31.
42. Huber-Lang M, et al. (2001) Role of C5a in multiorgan failure during sepsis. J. Immunol. 166:1193-9.
43. Riedemann NC, et al. (2002) C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16:887-8.
44. Laudes IJ, et al. (2002) Anti-c5a ameliorates coagulation/ fibrinolytic protein changes in a rat model of sepsis. Am. J. Pathol. 160:1867-75.
45. Abi-Gerges N, et al. (1999) Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat. Am. J. Respir. Crit. Care. Med. 160:1196-204.
46. Mebazaa A, et al. (2001) Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide. Circulation 104:3137-44.
47. Kreymann G, et al. (1993) Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit. Care Med. 21:1012-9.
48. Rudiger A, Singer M. (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit. Care Med. 35:1599-608.
49. Boekstegers P, Weidenhofer S, Kapsner T, Werdan K. (1994) Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit. Care Med. 22:640-50.
50. Boekstegers P, Weidenhofer S, Pilz G, Werdan K. (1991) Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection 19:317-23.
51. Rossi MA, Celes MR, Prado CM, Saggioro FP. (2007) Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 27:10-8.
52. Levy RJ, et al. (2005) Evidence of myocardial hibernation in the septic heart. Crit. Care Med. 33:2752-6.
53. Sharshar T, et al. (2003) Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362:1799-805.
54. Sharshar T, et al. (2004) The neuropathology of septic shock. Brain Pathol. 14:21-33.
55. Annane D, et al. (1999) Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am. J. Respir. Crit. Care Med. 160:458-65.
56. Korach M, et al. (2001) Cardiac variability in critically ill adults: influence of sepsis. Crit. Care Med. 29:1380-5.
57. Schmidt HB, Werdan K, Muller-Werdan U. (2001) Autonomic dysfunction in the ICU patient. Curr. Opin. Crit. Care 7:314-22.
58. Borovikova LV, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-62.
59. Huston JM, et al. (2007) Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit. Care Med. 35: 2762-8.
60. Tracey KJ. (2002) The inflammatory reflex. Nature 420:853-9.
61. Zhong J, Hwang TC, Adams HR, Rubin LJ. (1997) Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am. J. Physiol. 273:H2312-24.
62. 2+ current by interleukin-1 beta in cultured rat ventricular myocytes. Am. J. Physiol. 268:C339-49.
63. Lew WY, Yasuda S, Yuan T, Hammond HK. (1996) Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits. J. Mol. Cell Cardiol. 28:1367-71.
64. Tavernier B, Garrigue D, Boulle C, Vallet B, Adnet P. (1998) Myofilament calcium sensitivity is decreased in skinned cardiac fibres of endotoxin-treated rabbits. Cardiovasc. Res. 38:472-9.
65. 2+ sensitivity but normal mitochondrial function in septic heart. Am. J. Respir. Crit. Care Med. 163:362-7.
66. Shah AM. (1996) Paracrine modulation of heart cell function by endothelial cells. Cardiovasc. Res. 31:847-67.
67. Dong LW, Wu LL, Ji Y, Liu MS. (2001) Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. Shock 16:33-9.
68. Hagemann D, Xiao RP. (2002) Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc. Med. 12:51-6.
69. 2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium 38:291-302.
70. Wu LL, Ji Y, Dong LW, Liu MS. (2001) Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart. Shock 15:49-55.
71. Wu LL, Tang C, Dong LW, Liu MS. (2002) Altered phospholamban-calcium ATPase interaction in cardiac sarcoplasmic reticulum during the progression of sepsis. Shock 17:389-93.
72. Takeda K, Kaisho T, Akira S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21:335-76.
73. Frantz S, et al. (1999) Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:271-80.
74. Frantz S, Ertl G, Bauersachs J. (2007) Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 4:444-54.
75. Frantz S, Kelly RA, Bourcier T. (2001) Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J. Biol. Chem. 276:5197-203.
76. Nemoto S, et al. (2002) Escherichia coli LPS-induced LV dysfunction: role of Toll-like receptor-4 in the adult heart. Am. J. Physiol. Heart Circ. Physiol. 282:H2316-23.
77. Thomas JA, et al. (2003) IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 285:H597-606.
78. Baumgarten G, et al. (2001) In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of Toll-like receptor-4. J. Infect. Dis. 183:1617-24.
79. Ferrero E, et al. (1993) Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 90:2380-4.
80. Haziot A, et al. (1996) Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-14.
81. Knuefermann P, et al. (2002) CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation 106:2608-15.
82. Opie LH. Receptors and Signal Transduction. Lippincott Williams & Wilkins, London, 2004, p. 186-220.
83. Bocking JK, Sibbald WJ, Holliday RL, Scott S, Viidik T. (1979) Plasma catecholamine levels and pulmonary dysfunction in sepsis. Surg. Gynecol. Obstet. 148:715-9.
84. Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S. (1998) Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med. 24:1315-22.
85. Hahn PY, et al. (1995) Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock 4:269-73.
86. Iwase M, et al. (2001) Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. Crit. Care Med. 29:609-17.
87. Tang C, Liu MS. (1996) Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis. Am. J. Physiol. 270:R254-63.
88. Shepherd RE, Lang CH, McDonough KH. (1987) Myocardial adrenergic responsiveness after lethal and nonlethal doses of endotoxin. Am. J. Physiol. 252:H410-6.
89. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc. Natl. Acad. Sci. U. S. A. 86:6753-7.
90. Matsuda N, et al. (2000) Impairment of cardiac beta-adrenoceptor cellular signaling by decreased expression of G(s alpha) in septic rabbits. Anesthesiology. 93:1465-73.
91. Wu LL, et al. (2003) G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis. Shock 19:533-7.
92. Bohm M, Kirchmayr R, Gierschik P, Erdmann E. (1995) Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am. J. Med. 98:183-6.
93. Kyriakis JM, Avruch J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-69.
94. Baines CP, Molkentin JD. (2005) STRESS signaling pathways that modulate cardiac myocyte apoptosis. J. Mol. Cell. Cardiol. 38:47-62.
95. Liu Q, Hofmann PA. (2004) Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am. J. Physiol. Heart. Circ. Physiol. 286:H2204-12.
96. Bogoyevitch MA, et al. (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res. 79:162-73.
97. Cook SA, Sugden PH, Clerk A. (1999) Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J. Mol. Cell Cardiol. 31:1429-34.
98. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. (2001) Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ. Res. 89:201-10.
99. Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB. (1988) Inadequate collagen tethers in dilated cardiopathy. Am. Heart. J. 116:1641-6.
100. Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF Jr. (1996) Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy: role of metalloproteinases and pyridinoline cross-links. Am. J. Pathol. 148:1639-48.
101. Galis ZS, Khatri JJ. (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90:251-62.
102. Cheung PY, et al. (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101:1833-9.
103. Wang W, et al. (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106:1543-9.
104. Lalu MM, Gao CQ, Schulz R. (2003) Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9. Mol. Cell. Biochem. 251:61-6.
105. Wohlschlaeger J, et al. (2005) Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model. Pathol. Res. Pract. 201:809-17.
106. Boyle WA 3rd, et al. (2000) iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ. Res. 87:E18-24.
107. Belcher E, Mitchell J, Evans T. (2002) Myocardial dysfunction in sepsis: no role for NO? Heart 87:507-9.
108. Cotton JM, Kearney MT, Shah AM. (2002) Nitric oxide and myocardial function in heart failure: friend or foe? Heart 88:564-6.
109. Kumar A, et al. (1999) Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am. J. Physiol. 276:R265-76.
110. Paulus WJ, Vantrimpont PJ, Shah AM. (1994) Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation 89:2070-8.
111. Ullrich R, et al. (2000) Congenital deficiency of nitric oxide synthase 2 protects against endotoxininduced myocardial dysfunction in mice. Circulation 102:1440-6.
112. Ichinose F, et al. (2003) A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice. Am. J. Physiol. Heart Circ. Physiol. 285:H2524-30.
113. Barth E, et al. (2006) Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit. Care Med. 34:307-13.
114. Grover R, et al. (1999) An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit. Care Med. 27:913-22.
115. Ishida H, Ichimori K, Hirota Y, Fukahori M, Nakazawa H. (1996) Peroxynitrite-induced cardiac myocyte injury. Free Radic. Biol. Med. 20:343-50.
116. Xie YW, Kaminski PM, Wolin MS. (1998) Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ. Res. 82:891-7.
117. Lancel S, et al. (2004) Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J. Am. Coll. Cardiol. 43:2348-58.
118. Crouser ED. (2004) Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4:729-41.
119. Gellerich FN, et al. (2002) Mitochondrial dysfunction in sepsis: evidence from bacteraemic baboons and endotoxaemic rabbits. Biosci. Rep. 22:99-113.
120. Brealey D, et al. (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219-23.
121. Brealey D, et al. (2004) Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286:R491-7.
122. Crouser ED, Julian MW, Blaho DV, Pfeiffer DR. (2002) Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit. Care Med. 30:276-84.
123. Crouser ED, et al. (2004) Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia. Crit. Care Med. 32:478-88.
124. Suliman HB, Welty-Wolf KE, Carraway M, Tatro L, Piantadosi CA. (2004) Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc. Res. 64:279-88.
125. Watts JA, Kline JA, Thornton LR, Grattan RM, Brar SS. (2004) Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. J. Mol. Cell Cardiol. 36:141-50.
126. Soriano FG, et al. (2006) Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit. Care Med. 34:1073-9.
127. Levy RJ, Vijayasarathy C, Raj NR, Avadhani NG, Deutschman CS. (2004) Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 21:110-4.
128. Gellerich FN, et al. (1999) Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. Shock 11:336-41.
129. Trumbeckaite S, Opalka JR, Neuhof C, Zierz S, Gellerich FN. (2001) Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur. J. Biochem. 268:1422-9.
130. Taylor DE, Ghio AJ, Piantadosi CA. (1995) Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch. Biochem. Biophys. 316:70-6.
131. Levy RJ. (2007) Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock 28:24-8.
132. Fink MP. (2002) Bench-to-bedside review: cytopathic hypoxia. Crit. Care 6:491-9.
133. Fink MP. (2002) Cytopathic hypoxia: is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? Crit. Care Clin. 18:165-75.
134. Suliman HB, Carraway, MS, Piantadosi CA. (2003) Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am. J. Respir. Crit. Care Med. 167:570-9.
135. Larche J, et al. (2006) Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J. Am. Coll. Cardiol. 48:377-85.
136. Bergmann MW, Loser P, Dietz R, von Harsdorf R. (2001) Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis and downstream pathways in cardiomyocytes. J. Mol. Cell Cardiol. 33:1223-32.
137. Fauvel H, Marchetti P, Chopin C, Formstecher P, Neviere R. (2001) Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. Am. J. Physiol. Heart Circ. Physiol. 280:H1608-14.
138. McDonald TE, Grinman MN, Carthy CM, Walley KR. (2000) Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am. J. Physiol. Heart Circ. Physiol. 279: H2053-61.
139. Carlson D, Maass DL, White DJ, Tan J, Horton JW. (2006) Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses. Am. J. Physiol. Heart Circ. Physiol. 291:H2779-89.
140. Buerke U, et al. (2007) Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. Aug 2;Publish Ahead of Print.
141. Kumar A, et al. (2005) Human serum from patients with septic shock activates transcription factors STAT1, IRF1, and NF-kappaB and induces apoptosis in human cardiac myocytes. J. Biol. Chem. 280:42619-26.
142. Lancel S, et al. (2005) Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111: 2596-604.
143. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P. (2001) Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am. J. Respir. Crit. Care Med. 163:218-25.
144. Fauvel H, et al. (2002) Protective effects of cyclosporin A from endotoxin-induced myocardial dysfunction and apoptosis in rats. Am. J. Respir. Crit. Care Med. 165:449-55.
145. Lancel S, et al. (2005) Expression of apoptosis regulatory factors during myocardial dysfunction in endotoxemic rats. Crit. Care Med. 33:492-6.
146. Heusch G, Schulz R. (2000) The biology of myocardial hibernation. Trends Cardiovasc. Med. 10: 108-14.
147. Heusch G, Rose J, Skyschally A, Post H, Schulz R. (1996) Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart: inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 93:1556-66.
148. Sawyer DB, Loscalzo J. (2002) Myocardial hibernation: restorative or preterminal sleep? Circulation 105:1517-9.
149. Vanoverschelde JL, et al. (1997) Chronic myocardial hibernation in humans: from bedside to bench. Circulation 95:1961-71.
150. Elsasser A, et al. (1997) Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 96:2920-31.
151. Elsasser A, et al. (2004) Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J. Am. Coll. Cardiol. 43:2191-9.
152. Kalra DK, et al. (2002) Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation 105:1537-40.